Drugs and AKI

O Liangos1

  • 1Klinikum Coburg, III. Med. Klinik, Coburg, Germany. liangos_o@hotmail.com

Insights

Drug-induced acute kidney injury (AKI) is a significant concern in hospitalized patients. This review details the role of various medications, including aminoglycosides and NSAIDs, in causing AKI.

Area of Science:

  • Nephrology
  • Pharmacology
  • Internal Medicine

Background:

  • Acute kidney injury (AKI) is a frequent complication in hospitalized patients, significantly increasing morbidity and mortality.
  • Common causes include impaired renal perfusion, ischemia-reperfusion injury, sepsis, and urinary tract obstruction, often with multifactorial etiology.
  • Nephrotoxic medications play a crucial role in the development of AKI.

Purpose of the Study:

  • To evaluate the general importance of drug-related acute kidney injury.
  • To provide an in-depth review of specific drug classes implicated in AKI.
  • To offer an overview of drug-induced AKI, highlighting recently emerged or generally important agents.

Main Methods:

  • Review of existing literature on drug-induced acute kidney injury.
  • Selection and in-depth discussion of seven key drug classes: aminoglycosides, aristolochic acid, cytostatic drugs, nonsteroidal anti-inflammatory drugs (NSAIDs), osmotic agents, radiocontrast, and phosphate salts.
  • Analysis of epidemiology, pathophysiology, clinical features, and treatment for each selected drug class.

Main Results:

  • Drug-induced AKI is a significant contributor to overall AKI incidence in hospitalized populations.
  • Detailed insights into the mechanisms, clinical presentation, and management strategies for specific nephrotoxic agents were provided.
  • The review emphasizes the clinical relevance of understanding drug-induced nephrotoxicity.

Conclusions:

  • Nephrotoxic medications are an important, often overlooked, cause of acute kidney injury.
  • Understanding the specific properties of drugs like NSAIDs and aminoglycosides is critical for prevention and management.
  • This review provides a valuable resource for clinicians managing patients at risk of drug-induced AKI.

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...